deutsch
 | 
english

Older press releases

06.09.2007 US-Partner Avigen Commences Multicentric Phase II Study in the Development Programme for Tolperisone
24.08.2007 Sanochemia Nine-Month Report
23.08.2007 Corporate News: SANOCHEMIA Partner Avigen, Inc., reports successful
17.08.2007 Corporate News: Sanochemia files Scanlux in US
10.08.2007 Ad-hoc-Announcement according to § 15 WpHG Sanochemia Pharmazeutika AG – WKN 919963
26.07.2007 Ad-hoc-Announcement according to § 15 WpHG: Changes on the Board of Management at Sanochemia
31.05.2007 Corporate News to Sanochemia’s Half-Year Report 1.10.2006 – 31.3.2007
25.04.2007 SANOCHEMIA Ad-hoc announcement: Sanochemia receives regulatory approval for tolperisone formulation in Germany
19.03.2007 Report on Sanochemia’s 2007 Annual Shareholders' Meeting: Growth in turnover and profitability in all segments, R&D projects advanced further
14.03.2007 Cooperation with Richard Wolf GmbH to clinically develop PVP hypericin
12.03.2007 SANOCHEMIA’S R&D PROJECTS ATTRACT INTEREST AT BIO-EUROPE
12.03.2007 Current Research-Report of Landesbank Baden-Württemberg
09.03.2007 ECR 2007
23.02.2007 Corporate News - Sanochemia Q1 report: revenues rise – EBIT doubles
15.02.2007 Corporate News - European patent awarded for the manufacture of API tolperisone
05.02.2007 Corporate News - Phase IIa study with liposomal Galantamine successfully concluded
26.01.2007 Publication of annual results for the 2005/2006 financial year
19.01.2007 Sanochemia licenses further rights to tolperisone in Europe

 

Annual Shareholders' Meeting 2007

Sanochemia_Invitation_Annual_Shareholders_Meeting_2007_b9d8ac.pdf

Corparate_News_-_Information_on_Annual_Shareholders_Meeting_2007_73edb6.pdf

 

Financial Reports

2006/2007

2005/2006

2004/2005

2003/2004

2002/2003

2001/2002

2000/2001
Go to top
Print